1. Home
  2. LEA vs DNTH Comparison

LEA vs DNTH Comparison

Compare LEA & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lear Corporation

LEA

Lear Corporation

HOLD

Current Price

$131.32

Market Cap

6.3B

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$91.47

Market Cap

5.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEA
DNTH
Founded
1917
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.1B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
LEA
DNTH
Price
$131.32
$91.47
Analyst Decision
Buy
Strong Buy
Analyst Count
14
13
Target Price
$132.21
$121.00
AVG Volume (30 Days)
488.4K
834.4K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
2.39%
N/A
EPS Growth
N/A
N/A
EPS
8.15
N/A
Revenue
$23,259,100,000.00
$2,036,000.00
Revenue This Year
$2.50
N/A
Revenue Next Year
$3.12
$29.48
P/E Ratio
$15.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.62
$16.77
52 Week High
$142.84
$96.50

Technical Indicators

Market Signals
Indicator
LEA
DNTH
Relative Strength Index (RSI) 64.22 62.69
Support Level $115.26 $33.94
Resistance Level $142.84 N/A
Average True Range (ATR) 3.05 4.00
MACD 1.17 -0.56
Stochastic Oscillator 96.92 59.35

Price Performance

Historical Comparison
LEA
DNTH

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: